Skip main navigation

Military Health System

Clear Your Browser Cache

This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser's cache to ensure a seamless experience.

Surveillance Snapshot: Trends in Pharmacy Prescriptions by Therapeutic Class Among Active Component Members of the U.S. Armed Forces, 2014–2023

Image of 4alternate8102374. The Military Health System's Pharmacy Data Transaction Service includes prescription orders originating from military hospitals and clinics, mail order, and retail-dispensed facilities.

Annual Prescription Prevalence by AHFS Therapeutic Class, Active Component, 2014-2023. This graph comprises 10 lines on the horizontal, or x-, axis that depict the 10 drug therapeutic classes with the highest cumulative period prevalence proportions for each year from 2014 to 2023. The x-, or horizontal, axis presents each year during the 10 year period. The y-, or vertical, axis presents percent prevalence of each drug. Each line connects 10 points that represent the annual prevalence of a specific drug class. Central nervous system agents were, by far, the drug class with the highest prevalence, ranging from a high of nearly 65 percent in 2015 to a low of around 50 percent in 2020, where it has remained ever since. All other drug classes are consistently below 35 percent prevalence, with anti-infective agents consistently the second most prevalent and, at only slightly less prevalence, ear, nose and throat preparations the third most prevalent. All prescriptions declined in prevalence between 2019 and 2020, but have remained steady or gradually increased to former prevalence levels thereafter.   This Surveillance Snapshot presents trends in pharmacy prescriptions ordered from 2014 to 2023 for active component service members of the U.S. Army, Navy, Air Force, Marine Corps, Coast Guard, and Space Force. Pharmacy prescriptions were queried from the Pharmacy Data Transaction Service, which includes prescription orders originating from military hospitals and clinics, mail order, and retail-dispensed facilities. The American Hospital Formulary System1 pharmacologic-therapeutic codes were utilized to identify ACSMs with pharmacy orders under a first-tier class (2-digit therapeutic class codes) each year. The annual prevalence of each therapeutic class was calculated per person using mid-year estimates for all ACSMs. The figure depicts AHFS classes representing the 10 highest cumulative period prevalence proportions.

Throughout the 10-year period, central nervous system agents accounted for the highest prescription prevalence. Of the 658,598 ACSMs with prescriptions for a CNS agent in 2023, the leading three prescription orders for ACSMs further classified under a 6-digit AFHS code included other nonsteroidal anti-inflammatory agents (n=424,968; code 280804), analgesics and antipyretics (n=285,082; code 280892), and tricyclics other norepinephrine-reuptake inhibitors (n=172,790; code 281604). Excluding cardiovascular drugs, the prevalence of ACSMs receiving prescription orders decreased in all 9 other therapeutic classes during the SARS-CoV-2 pandemic. From 2019 to 2021, the largest prevalence declines were observed for respiratory tract agents (17.7% to 8.9%), EENT preparations (32.1% to 22.4%), antihistamine drugs (17.6% to 12.3%), autonomic drugs (25.7% to 18.7%), and anti-infective agents (32.6% to 24.8%). Following the pandemic, the prevalence of ACSMs receiving prescription orders during 2023 increased to a highest point observed over the 10-year surveillance period within 2 therapeutic classes, including respiratory tract agents (19.0%) and skin and mucous membrane agents (23.9%).

Two additional therapeutic classes not depicted in the figure demonstrated substantial prevalence increases during the surveillance period. From 2014 to 2023, the prevalence of ACSMs with orders for serum/toxoid/vaccines (class 8000000) increased from 2.4% to 11.6% and miscellaneous therapeutic agents (class 920000) increased from 8.7% to 14.4%. While PDTS includes prescriptions covered under the TRICARE health benefit, intended to provide primary health care coverage for all ACSMs, it does not document over-the-counter medications. Thus, the results presented in this Surveillance Snapshot may underestimate true prevalence for some therapeutic classes.

Author Affiliations

Epidemiology and Analysis Section, Armed Forces Health Surveillance Division, Defense Health Agency

Reference

  1. American Society of Health System Pharmacists. AFHS Pharmacologic-Therapeutic Classification. 2023. Accessed Jun. 12, 2023. https://ahfsdruginformation.com/ahfs-classification-drug-assignments

You also may be interested in...

Article
Jun 1, 2022

Absolute and Relative Morbidity Burdens Attributable to Various Illnesses and Injuries, Non-service Member Beneficiaries of the Military Health System, 2021

In 2021, mental health disorders accounted for the largest proportions of the morbidity and health care burdens that affected the pediatric and younger adult beneficiary age groups. Among adults aged 45–64 and those aged 65 or older, musculoskeletal diseases accounted for the most morbidity and health care burdens. As in previous years, this report ...

Article
Jun 1, 2022

Hospitalizations, Active Component, U.S. Armed Forces, 2021

The hospitalization rate in 2021 was 48.0 per 1,000 person-years (p-yrs), the second lowest rate of the most recent 10 years. For hospitalizations limited to military facilities, the rate in 2021 was the lowest for the entire period. As in prior years, the majority (71.2%) of hospitalizations were associated with diagnoses in the categories of mental ...

Article
Jun 1, 2022

Absolute and Relative Morbidity Burdens Attributable to Various Illnesses and Injuries, Active Component, U.S. Armed Forces, 2021

In 2021, as in prior years, the medical conditions associated with the most medical encounters, the largest number of affected service members, and the greatest number of hospital days were in the major categories of injuries, musculoskeletal disorders, and mental health disorders. Despite the pandemic, COVID-19 accounted for less than 2% of total ...

Article
Jun 1, 2022

Ambulatory Visits, Active Component, U.S. Armed Forces, 2021

In 2021, the overall numbers and rates of active component service member ambulatory care visits were the highest of any of the last 10 years. Most categories of illness and injury showed modest increases in numbers and rates. The proportions of ambulatory care visits that were accomplished via telehealth encounters fell to under 15% in 2021, compared ...

Article
Jun 1, 2022

Medical Evacuations out of the U.S. Central and U.S. Africa Commands, Active and Reserve Components, U.S. Armed Forces, 2021

The proportions of evacuations out of USCENTCOM that were due to battle injuries declined substantially in 2021. For USCENTCOM, evacuations for mental health disorders were the most common, followed by non-battle injury and poisoning, and signs, symptoms, and ill-defined conditions. For USAFRICOM, evacuations for non-battle injury and poisoning were ...

Article
May 1, 2022

The Association Between Two Bogus Items, Demographics, and Military Characteristics in a 2019 Cross-sectional Survey of U.S. Army Soldiers

NIANTIC, CT, UNITED STATES 06.16.2022 U.S. Army Staff Sgt. John Young, an information technology specialist assigned to Joint Forces Headquarters, Connecticut Army National Guard, works on a computer at Camp Nett, Niantic, Connecticut, June 16, 2022. Young provided threat intelligence to cyber analysts that were part of his "Blue Team" during Cyber Yankee, a cyber training exercise meant to simulate a real world environment to train mission essential tasks for cyber professionals. (U.S. Army photo by Sgt. Matthew Lucibello)

Data from surveys may be used to make public health decisions at both the installation and the Department of the Army level. This study demonstrates that a vast majority of soldiers were likely sufficiently engaged and answered both bogus items correctly. Future surveys should continue to investigate careless responding to ensure data quality in ...

Article
May 1, 2022

Update: Sexually Transmitted Infections, Active Component, U.S. Armed Forces, 2013–2021

This illustration depicts a 3D computer-generated image of a number of drug-resistant Neisseria gonorrhoeae bacteria. CDC/James Archer

This report summarizes incidence rates of the 5 most common sexually transmitted infections (STIs) among active component service members of the U.S. Armed Forces during 2013–2021. In general, compared to their respective counterparts, younger service members, non-Hispanic Black service members, those who were single and other/unknown marital status, ...

Skip subpage navigation
Refine your search
Last Updated: July 26, 2024
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on X Follow us on YouTube Sign up on GovDelivery